Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA. Email:
Sci Transl Med. 2017 Mar 29;9(383). doi: 10.1126/scitranslmed.aan0769.
The NLRP3 inflammasome/caspase-1/IL-1β axis may be a therapeutic target in severe steroid-resistant asthma.
NLRP3 炎性小体/半胱天冬酶-1/IL-1β 轴可能是重症激素抵抗性哮喘的治疗靶点。
